Model
Edge
Moonlake Immunotherapeutics
0001920509
Filing Type
4
Filing Date
2/22/2024
Updated
2/23/24, 9:48 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership